• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US SUMMIT DUOFIX TAP SZ2 HI OFF; SUMMIT HIP STEM : HIP FEMORAL STEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US SUMMIT DUOFIX TAP SZ2 HI OFF; SUMMIT HIP STEM : HIP FEMORAL STEM Back to Search Results
Catalog Number 157012080
Medical Device Problem Code Biocompatibility (2886)
Health Effect - Clinical Codes Pain (1994); Tissue Damage (2104); Test Result (2695); No Code Available (3191)
Date of Event 04/24/2013
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Product complaint #: (b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.(b)(4).Attorney.
 
Event or Problem Description
Litigation alleges pain and suffering.Update rec¿d 2/3/2014 - pfs was received from legal, primary and revision medical records were received from legal, and part/lot information was identified.Records indicate that the patient was revised because of pain and "metalosis".Update ad 04 may 2018: (b)(4) has been re-opened under (b)(4) due to the receipt of ppf and sticker sheets.In addition to what were previously alleged, ppf alleges dislocation with closed reduction, metal wear and elevated metal ions.
 
Additional Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Product complaint #
=
> (b)(4).Investigation summary
=
> no device associated with this report was received for examination.A worldwide complaint database search found no other reported incident(s) against the provided product/lot combination(s) since release for distribution.Based on previous investigations this complication of joint replacement is unlikely to have been the result of a device failing to meet required specifications.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Corrective action was not indicated.If information is obtained that was not available for the initial medwatch, a follow-up medwatch, a follow-up medwatch will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUMMIT DUOFIX TAP SZ2 HI OFF
Common Device Name
SUMMIT HIP STEM : HIP FEMORAL STEM
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46582 0988
MDR Report Key8217021
Report Number1818910-2019-79858
Device Sequence Number1631369
Product Code LPH
UDI-Device Identifier10603295060130
UDI-Public10603295060130
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K011489
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2009
Reporter Type Manufacturer
Report Source consumer,other
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 12/10/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number157012080
Device Lot NumberZ56A51000
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 12/10/2018
Supplement Date Received by Manufacturer05/02/2019
Initial Report FDA Received Date01/04/2019
Supplement Report FDA Received Date05/02/2019
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age50 YR
Patient Weight68
-
-